Pfizer says booster in kids 5-11 produces ‘high’ immune response

Pfizer and BioNTech said Thursday that a third dose of their COVID-19 vaccine in children 5 to 11 produced a “high” immune response, and that they will apply for authorization for a booster dose in the age group soon.